Mark A. Schallenberger - 15 Feb 2026 Form 4 Insider Report for Xtant Medical Holdings, Inc. (XTNT)

Role
Chief Operating Officer
Signature
/s/ Amy Culbert, attorney-in-fact
Issuer symbol
XTNT
Transactions as of
15 Feb 2026
Net transactions value
-$4,471
Form type
4
Filing time
18 Feb 2026, 16:36:56 UTC
Previous filing
18 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Schallenberger Mark A. Chief Operating Officer C/O XTANT MEDICAL HOLDINGS, INC., 664 CRUISER LANE, BELGRADE /s/ Amy Culbert, attorney-in-fact 18 Feb 2026 0001960742

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XTNT Common Stock Tax liability $4,471 -7,709 -1.1% $0.5800 663,157 15 Feb 2026 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were withheld by the Issuer to pay tax withholding obligations upon vesting and settlement of restricted stock unit awards.
F2 Includes an aggregate of 523,794 shares issuable upon vesting and settlement of restricted stock unit (RSU) awards or DSU awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan and 22,250 shares issuable upon vesting and settlement of RSU awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, in each case conditioned upon the Reporting Person remaining an employee of Xtant through the applicable vesting dates.